TY - JOUR
T1 - Parental age at delivery and incidence of breast cancer
T2 - A prospective cohort study
AU - Xue, Fei
AU - Colditz, Graham A.
AU - Willett, Walter C.
AU - Rosner, Bernard A.
AU - Michels, Karin B.
N1 - Funding Information:
Acknowledgements The Nurses’ Health Study is supported by grant CA87969 from the National Cancer Institute, National Institute of Health.
PY - 2007/9
Y1 - 2007/9
N2 - Background: Studies on parental age at delivery in relation to breast cancer risk have had mixed results, but prospective data are limited. No study has explored the associations with subtypes of breast cancer defined by hormonal receptor status. Methods: 109,773 women in the Nurses' Health Study were followed from 1976 to 2002. We used Cox proportional hazards model to examine the association between parental age at delivery and daughters' risk of breast cancer. Results: 6,827 incident cases of invasive breast cancer occurred in this cohort during 2,581,098 person-years. Adjusting for other early life exposures and family history of breast cancer, the hazard ratio for breast cancer in women born to mothers aged 21-25, 26-30, 31-35, and ≥36 years was, respectively, 1.08 (95% CI: 0.99-1.18), 1.12 (95% CI: 1.03-1.23), 1.17 (95% CI: 1.06-1.29), and 1.12 (95% CI: 1.01-1.25), compared to women born to mothers aged ≤20 years (P for trend = 0.008). Similarly, advanced paternal age was associated with increased incidence of breast cancer (P for trend = 0.03), but the association disappeared when conditioning on maternal age. The positive association between maternal age and incidence of breast cancer was stronger for estrogen receptor-positive and progesterone receptor-positive tumors (P for trend = 0.003) than for tumors with both receptors negative (P for trend = 0.78), and was more consistent among postmenopausal women, women without a family history and women who were first born. Conclusion: Our findings support a modest positive association between maternal age and daughter's risk of breast cancer, possibly mediated by hormonal factors.
AB - Background: Studies on parental age at delivery in relation to breast cancer risk have had mixed results, but prospective data are limited. No study has explored the associations with subtypes of breast cancer defined by hormonal receptor status. Methods: 109,773 women in the Nurses' Health Study were followed from 1976 to 2002. We used Cox proportional hazards model to examine the association between parental age at delivery and daughters' risk of breast cancer. Results: 6,827 incident cases of invasive breast cancer occurred in this cohort during 2,581,098 person-years. Adjusting for other early life exposures and family history of breast cancer, the hazard ratio for breast cancer in women born to mothers aged 21-25, 26-30, 31-35, and ≥36 years was, respectively, 1.08 (95% CI: 0.99-1.18), 1.12 (95% CI: 1.03-1.23), 1.17 (95% CI: 1.06-1.29), and 1.12 (95% CI: 1.01-1.25), compared to women born to mothers aged ≤20 years (P for trend = 0.008). Similarly, advanced paternal age was associated with increased incidence of breast cancer (P for trend = 0.03), but the association disappeared when conditioning on maternal age. The positive association between maternal age and incidence of breast cancer was stronger for estrogen receptor-positive and progesterone receptor-positive tumors (P for trend = 0.003) than for tumors with both receptors negative (P for trend = 0.78), and was more consistent among postmenopausal women, women without a family history and women who were first born. Conclusion: Our findings support a modest positive association between maternal age and daughter's risk of breast cancer, possibly mediated by hormonal factors.
KW - Breast cancer
KW - Epidemiology
KW - Hormone receptor
KW - Maternal age
KW - Paternal age
KW - Prospective cohort
UR - http://www.scopus.com/inward/record.url?scp=34547771584&partnerID=8YFLogxK
U2 - 10.1007/s10549-006-9424-4
DO - 10.1007/s10549-006-9424-4
M3 - Article
C2 - 17115113
AN - SCOPUS:34547771584
SN - 0167-6806
VL - 104
SP - 331
EP - 340
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -